Fact Sheets

© Frost & Sullivan 2023 The Growth Pipeline Company™ Best Practices Criteria for World-Class Performance Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient. The process involves a detailed evaluation of best practices criteria across two dimensions for each nominated company. ArisGlobal excels in many of the criteria in the life sciences pharmacovigilance and data analytics software space. ArisGlobal Owing to the high need to study drug side effects, conduct risk-benefit analysis, and monitor and prevent adverse drug reactions bearing high mortality and morbidity costs, pharmacovigilance for safer drug intake is vital. The rise in drug discovery and development stresses the global pharmacovigilance market to produce high-quality results quickly coupled with analytics on available data volumes. Life sciences organizations continue to apply manual processes and deploy subpar technology systems, which limits productivity and accuracy. Founded in 1987 and headquartered in Miami, Florida, ArisGlobal provides a cloud-based, automated, integrated life sciences technology platform. For over three decades, its market-leading solution LifeSphere® has supported life science organizations for pharmacovigilance, clinical activities, and regulatory processes to deliver drug products from bench to bedside safely, quickly, and cost-effectively. Additionally, it ensures 100% compliance with current and upcoming regulatory standards. The company operates globally with regional offices in Europe, India, Japan, and China. It offers the most comprehensive global and regional out-of-the-box compliance spanning regulators worldwide and regionally across 37 countries, including Asia Pacific (APAC) and Latin American countries, for different product types.

• Cover